基本信息
浏览量:329
职业迁徙
个人简介
He currently splits his time between patient care and directing the Translational Research Laboratory in the Division of Hematology/Oncology. His research interests are focused in the development of targeted therapeutics for solid tumors across histologies to support the larger efforts of the department. His personal interests lie in the development of these targeted agents in Hepato-biliary and breast cancers. He has two-half days dedicated to patient care, one of which is as a leader in the multi-disciplinary hepato-biliary cancer program at UCLA where he is involved with clinical studies aimed at bringing novel therapeutics into the treatment of patients with these malignancies.
研究兴趣
论文共 569 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FUTURE ONCOLOGYno. 1 (2024): 5-16
Richard S. Finn,Shukui Qin,Fabio Piscaglia, Thomas R Jeffry Evans,Jennifer J. Knox,Carlos López López, Zahra Ramji,Min Ren,Kalgi Mody,Arndt Vogel,Masatoshi Kudo
Liver Cancer (2024)
Zenodo (CERN European Organization for Nuclear Research) (2024)
引用0浏览0引用
0
0
Nature Medicineno. 3 (2024): 699-707
JAMA oncologyno. 3 (2024): 1-1
John D Gordan,Erin B Kennedy,Ghassan K Abou-Alfa,Eliza Beal,Richard S Finn, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang,Renuka Iyer,Ishmael Jaiyesimi,
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2302745-JCO2302745, (2024)
JAMA oncologyno. 3 (2024): 395-404
Josep M. Llovet, Roser Pinyol,Mark Yarchoan, Amit G. Singal,Thomas U. Marron, Myron Schwartz,Eli Pikarsky, Masatoshi Kudo,Richard S. Finn
Nature Reviews Clinical Oncologyno. 4 (2024): 294-311
Liver Cancer (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn